Genicular Artery Embolization (GAE) represents a new paradigm in treating knee osteoarthritis that had hitherto been handled ...
Individuals with type 2 diabetes and painful symptomatic knee osteoarthritis are less likely to achieve target glycemic ...
Osteoarthritis (OA) remains one of the leading causes of disability worldwide, burdening health systems and diminishing quality of life ...
ZME Science on MSN
Obesity Patients Lost Nearly 30 percent of Their Body Weight on a New Experimental Drug and Many Saw Their Knee Pain Disappear
In a new clinical trial, people with obesity and knee osteoarthritis who took an experimental drug from Eli Lilly lost large ...
Rutgers Health experts have expanded treatment options for knee osteoarthritis, a condition caused by the gradual breakdown ...
Self-reported knee crepitus may predict osteoarthritis 1 year following ACL reconstruction, according to findings published ...
SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic ...
Organogenesis Holdings ($ORGO) announced an update on their ongoing clinical study. Study Overview Organogenesis Holdings (ORGO) is sponsoring a ...
TipRanks on MSN
Pacira ends hip osteoarthritis injection study for ZILRETTA: What investors should know
Pacira ($PCRX) announced an update on their ongoing clinical study. Study Overview: Pacira Pharmaceuticals is running a Phase 2 trial titled “A ...
Lifestyle adjustments like maintaining a healthy weight and engaging in regular, low impact exercise can significantly alleviate osteoarthritis symptoms, particularly in the knees and hips. Various ...
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 TRIUMPH-4 clinical trial ...
A generic product for managing pain and inflammation associated with osteoarthritis (OA) in canines has been approved by FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback